bluebird bio (BLUE) Misses Q4 EPS by 10c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Bluebird Bio (BLUE) PT Lifted to $119 at Piper Jaffray
February 26, 2015 8:43 AM ESTPiper Jaffray analyst Joshua Schimmer raised his price target on Overweight-rated Bluebird Bio (NASDAQ: BLUE) to $119.00 (from $112.00) following Q4 earnings.
Schimmer commented, "BLUE released 4Q14 earnings Wednesday evening disclosing a cash/cash equivalent balance of $492.0M. The company continues to advance its... More



